Clinical Trial: Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo (Nepafenac Vehicle) for the Prevention and Treatment of Ocular Inflammation and Cure is defined as aqueous cells score = 0 and aqueous cells score = 0 at Day 14.



Original Primary Outcome: Percentage of patients with Day 14 cure (inflammation score = 0)

Current Secondary Outcome:

Original Secondary Outcome: Mean aqueous cells and flare scores, percentage of treatment failures and of patients with clinically significant inflammation, and assessment of ocular pain, at each visit

Information By: Alcon Research

Dates:
Date Received: November 29, 2006
Date Started: November 2005
Date Completion:
Last Updated: November 16, 2016
Last Verified: April 2012